{"symbol":"AMGN","fiscalQuarter":"Q3-2020","reportDate":"2020-10-28","reportTime":"AMC","status":"reported","company":{"name":"Amgen Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2020","postBrief":{"headline":"Amgen Beats on EPS, Stock Down 3.17%","keyNumbers":[{"metric":"EPS","actual":"$4.37","expected":"N/A","surprise":"+16.66%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed confidence in the company's long-term growth prospects.","They highlighted ongoing investments in research and development."],"summary":"Overall, management remains positive about future opportunities despite current market challenges. They emphasized the importance of innovation."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Amgen's earnings report shows a strong performance in EPS, exceeding expectations by a notable margin. However, the stock fell by 3.17% in reaction, likely due to the lack of revenue details and no guidance for future performance. Investors may be cautious given the uncertainty in the market.","metaDescription":"Amgen Inc (AMGN) Q3 2020 earnings: EPS beat by 16.66%. Stock down 3.17%. Full breakdown."}}